Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy

We identified pyrvinium pamoate, an old anthelminthic medicine, which preferentially inhibits anchorage-independent growth of cancer cells over anchorage-dependent growth (∼10 fold). It was also reported by others to have anti-tumor activity in vivo and selective toxicity against cancer cells under glucose starvation in vitro, but with unknown mechanism. Here, we provide evidence that pyrvinium suppresses the transcriptional activation of GRP78 and GRP94 induced by glucose deprivation or 2-deoxyglucose (2DG, a glycolysis inhibitor), but not by tunicamycin or A23187. Other UPR pathways induced by glucose starvation, e.g. XBP-1, ATF4, were also found suppressed by pyrvinium. Constitutive expression of GRP78 via transgene partially protected cells from pyrvinium induced cell death under glucose starvation, suggesting that suppression of the UPR is involved in pyrvinium mediated cytotoxicity under glucose starvation. Xenograft experiments showed rather marginal overall anti-tumor activity for pyrvinium as a monotherapy. However, the combination of pyrvinium and Doxorubicin demonstrated significantly enhanced efficacy in vivo, supporting a mechanistic treatment concept based on tumor hypoglycemia and UPR.

[1]  Amy S. Lee,et al.  Induction of Grp78/BiP by Translational Block , 2003, Journal of Biological Chemistry.

[2]  S. Long,et al.  PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway. , 2006, Experimental cell research.

[3]  E. Winer,et al.  American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Koong,et al.  XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. , 2004, Cancer research.

[5]  Amy S. Lee.  GRP78 induction in cancer: therapeutic and prognostic implications. , 2007, Cancer research.

[6]  Amy S. Lee,et al.  Requirement of the p38 mitogen-activated protein kinase signalling pathway for the induction of the 78 kDa glucose-regulated protein/immunoglobulin heavy-chain binding protein by azetidine stress: activating transcription factor 6 as a target for stress-induced phosphorylation. , 2002, The Biochemical journal.

[7]  R. Kaufman,et al.  All roads lead to ATF4. , 2003, Developmental cell.

[8]  A. S. Lee,et al.  Identification of highly conserved regulatory domains and protein-binding sites in the promoters of the rat and human genes encoding the stress-inducible 78-kilodalton glucose-regulated protein , 1988, Molecular and cellular biology.

[9]  Demin Zhou,et al.  A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing. , 2006, Experimental cell research.

[10]  H. Esumi,et al.  Antitumor activity of pyrvinium pamoate, 6‐(dimethylamino)‐2‐[2‐(2,5‐dimethyl‐1‐phenyl‐1H‐pyrrol‐3‐yl)ethenyl]‐1‐methyl‐quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation , 2004, Cancer science.

[11]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[12]  A. El-Zawahry,et al.  Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts , 2005, BMC Cancer.

[13]  S. Tsutsumi,et al.  Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells , 2006, Oncogene.

[14]  K. Mori,et al.  Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. , 2003, Journal of Hepatology.

[15]  P. Walter,et al.  Intracellular signaling by the unfolded protein response. , 2006, Annual review of cell and developmental biology.

[16]  S. Patierno,et al.  Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions , 2004, Breast Cancer Research and Treatment.

[17]  R. Sood,et al.  Translational Control -subunit Kinase, Pek, Involved in Α Pancreatic Eukaryotic Initiation Factor 2 Identification and Characterization Of , 1998 .

[18]  J. Aguirre-Ghiso,et al.  Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. , 2006, Cancer research.

[19]  Y. Park,et al.  Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. , 2001, Cancer research.

[20]  X. Cao,et al.  Transactivation of the grp78 promoter by Ca2+ depletion. A comparative analysis with A23187 and the endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin. , 1993, The Journal of biological chemistry.

[21]  F. Wong-Staal,et al.  One-week 96-well soft agar growth assay for cancer target validation. , 2004, BioTechniques.

[22]  Amy S. Lee,et al.  Glucose regulated proteins in cancer progression, Drug resistance and immunotherapy , 2006, Cancer biology & therapy.

[23]  K. Kinzler,et al.  The multistep nature of cancer. , 1993, Trends in genetics : TIG.

[24]  W. Arap,et al.  Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. , 2004, Cancer cell.

[25]  C. Koumenis,et al.  The PERK/eIF2α/ATF4 module of the UPR in hypoxia resistance and tumor growth , 2006 .

[26]  Amy S. Lee,et al.  The Endoplasmic Reticulum Chaperone Glycoprotein GRP94 with Ca2+-binding and Antiapoptotic Properties Is a Novel Proteolytic Target of Calpain during Etoposide-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[27]  C. Koumenis,et al.  The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. , 2006, Cancer biology & therapy.

[28]  Takashi Tsuruo,et al.  Effect on tumor cells of blocking survival response to glucose deprivation. , 2004, Journal of the National Cancer Institute.

[29]  D. Ron,et al.  Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase , 1999, Nature.

[30]  Amy S. Lee,et al.  De‐regulation of GRP stress protein expression in human breast cancer cell lines , 1999, Breast Cancer Research and Treatment.

[31]  R. Kaufman,et al.  A trip to the ER: coping with stress. , 2004, Trends in cell biology.

[32]  F. Wong-Staal,et al.  A 96-well surrogate survival assay coupled with a special short interfering RNA vector for assessing cancer gene targets with enhanced signal/noise ratio and its utility in HTS for cancer therapeutic targets. , 2005, Assay and drug development technologies.

[33]  Randal J. Kaufman,et al.  Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors , 2003, Journal of Biological Chemistry.

[34]  K. Kato,et al.  Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. , 2000, Cancer research.

[35]  M. Volm,et al.  Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas. , 1999, Anticancer research.